Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-22

Clinical Trial Update: A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in Singapore evaluating genomic-guided standard-of-care chemotherapy for recurrent/advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Recurrent Gastric Cancer | Phase 2 | Status: UNKNOWN